⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRTC News
PureTech Health plc American Depositary Shares
PureTech Announces Annual Results for Year Ended December 31, 2025
businesswire.com
PRTC
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
businesswire.com
PRTC
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
businesswire.com
PRTC
BNTC
PureTech Health: Notice of Results
businesswire.com
PRTC
PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
businesswire.com
PRTC
PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
businesswire.com
PRTC
PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo ™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
businesswire.com
PRTC
Particula Launches the Digital Asset Risk Passport (PDARP) - Programmable Risk Infrastructure for Onchain Capital Markets
globenewswire.com
PRTC
proteanTecs、TOPPANグループのコーポレートベンチャーであるTGVPより戦略的投資を獲得
businesswire.com
PRTC
PureTech to Present at the Leerink Partners Global Healthcare Conference
businesswire.com
PRTC